Partner Hospitals

Founded in 1947, it enjoys a high reputation in organ transplantation, infectious diseases, hematological diseases, kidney diseases, urinary system diseases and clinical pharmacy. It is one of China’s medical centers with the most complete range of large organ transplantation procedures.

Founded in 1921, it is one of the earliest hospitals tasked with providing medical services for foreign guests. Annual surgeries exceed 70,000, and annual inpatient admissions are over 120,000. It hosts 6 national-level research platforms, including the National Key Laboratory for Severe, Complex and Rare Diseases, the National Major Science and Technology Infrastructure for Translational Medicine, the National Clinical Research Center for Obstetric and Gynecologic Diseases, and the National Clinical Research Center for Skin and Immune Diseases.

Founded in 1892, it is China’s first medical institution certified as an International Comprehensive Stroke Center by the World Stroke Organization. Specialties including rheumatology and immunology, orthopedics, obstetrics and gynecology, endocrinology and neurology rank among the top in China. It has established friendly ties with more than 20 international partner hospitals across 13 countries on five continents. Luoyang Orthopedic Hospital of Henan Province

Founded in 1869, the hospital has set national benchmarks including the “Hangzhou Protocol” for transcatheter heart valve replacement, minimally invasive complex cataract surgery, standardized diagnosis and treatment of colorectal tumors, and mass severe trauma rescue. The perioperative survival rate of pediatric liver transplantation is at the internationally leading level.

Founded in 1892, it has reached leading domestic and international standards in many fields, such as adult living donor liver transplantation, early diagnosis and treatment of lung cancer, cardiac interventional therapy, neurosurgery and functional neurosurgery, integrated traditional Chinese and Western medicine for severe pancreatitis, and allogeneic combined larynx-trachea-thyroid transplantation.

Founded in 1957, it is China’s first Grade A tertiary specialized hospital focusing on the diagnosis and treatment of cardiothoracic diseases after the founding of the People’s Republic of China. Centered on two major discipline clusters: thoracic tumors and cardiovascular diseases, it masters the most extensive spectrum and full range of diagnostic and therapeutic technologies for cardiothoracic diseases in China. Annual outpatient and emergency visits exceed 860,000, with more than 28,000 surgeries performed each year. The proportion of Grade-III and Grade-IV surgeries is over 90%. Its surgical volume for tracheal and mediastinal tumors ranks No.1 nationwide, lung tumor surgery volume ranks No.2 nationwide, and esophageal surgery volume is among the top in China and ranks No.1 in the city.

Founded in 1937. Its clinical capabilities in the fields of heart, liver, kidney, lung, digestive tract and panvascular diseases are at the top domestic and world-advanced level. The hospital is fully equipped with world-class diagnostic and therapeutic equipment including Da Vinci surgical robots, 3.0T high-field MRI, PET-CT, high-end DSA interventional systems and precision radiotherapy devices. More than 90 MDT teams have been established. Annual outpatient and emergency visits exceed 6.1 million, inpatient admissions over 280,000, and inpatient surgeries more than 210,000.